Company registration number:
09390160
Spring Raise LTD
Trading as
Spring Raise
Unaudited filleted financial statements
31 January 2026
Spring Raise LTD
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Spring Raise LTD
Directors and other information
|
|
|
|
Directors |
Mr Ade Oyewole Asefeso |
|
|
|
|
|
|
|
Company number |
09390160 |
|
|
|
|
|
|
|
Registered office |
20 Grosvenor Avenue |
|
|
Hayes |
|
|
UB4 8NL |
|
|
|
|
|
|
|
Business address |
268 Bath Road |
|
|
Slough |
|
|
Berkshire |
|
|
SL1 4DX |
|
|
|
|
|
|
|
Accountants |
Accountant Services Ltd |
|
|
Winnersh Triangle |
|
|
Building 220 |
|
|
Wharfedale Road |
|
|
Wokingham |
|
|
RG41 5TP |
|
|
|
Spring Raise LTD
Statement of financial position
31 January 2026
|
|
|
2026 |
|
2025 |
|
|
|
|
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
87,808 |
|
- |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
28,586 |
|
62,540 |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
(
5,192) |
|
(
11,727) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Net current assets |
|
|
23,394 |
|
50,813 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
111,202 |
|
50,813 |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due after more than one year |
|
|
(
109,846) |
|
(
107,230) |
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Net assets/(liabilities) |
|
|
1,356 |
|
(
56,417) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
1,356 |
|
(
56,417) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
Notes to the financial statements
Spring Raise LTD
Year ended 31 January 2026
1.
Employee numbers
The average number of persons employed by the company during the year amounted to
9
(2025:
36
).
2.
Capital commitments
Capital expenditure contracted for but not provided for in the financial statements is as follows:
|
|
|
2026 |
2025 |
|
|
|
£ |
£ |
|
Intangible assets |
|
87,808 |
- |
|
|
|
_______ |
_______ |
|
|
|
|
|
The Research and Development expenditure of £87,808 comprises costs associated with securing a National Health Service contract awarded in 2025, investment in software required to support delivery of the new contract, and expenses related to ISO accreditation.
3.
Directors advances, credits and guarantees
|
|
Balance brought forward and o/standing |
Balance brought forward and o/standing |
|
|
2026 |
2025 |
|
|
£ |
£ |
|
Mr Ade Oyewole Asefeso |
278,664 |
188,280 |
|
|
_______ |
_______ |
|
|
|
|
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
08 May 2026
, and are signed on behalf of the board by:
Mr Ade Oyewole Asefeso
Director
Company registration number:
09390160
The company is a private company limited by shares, registered in .